Gulbin, Jerian .

HRN: 28-60-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/20/2026
02/27/2026
PO
4.5 Ml
Q 12
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines